Session: Drug Delivery I - Targeted Delivery and Triggered Release (2009 Annual Meeting)

Description:

This session deals with the latest advances in drug delivery methods and related technologies. Specific topics of interest include (not limited to) novel materials and devices for drug delivery, targeting strategies, conjugation/loading/release of new therapeutics, and synergistic technologies with drug delivery (e.g., combined imaging and therapy). New theoretical findings and useful biological models (in vitro and in vivo; diseases) for drug delivery are also welcome.

Sponsor:

Engineering Fundamentals in Life Science

Chair:

Omolola Eniola-Adefeso
Assistant Professor
University of Michigan
Chemical Engineering
2300 Hayward St.
Ann Arbor, MI 48109
Phone Number: 713-373-9563
Email: aeniol1@yahoo.com

Co-Chair:

Young Jik Kwon

Papers:

512a

pH-Triggered Leaky Heterogeneities On Rigid Lipid Bilayers Accelerate Intracellular Trafficking of Doxorubicin and Improve the Therapeutic Potential of Targeted Liposomal Immunochemotherapy
Shrirang Karve, Polytechnic Institute of NYU; Ali Alaouie, Polytechnic Institute of NYU; Stavroula Sofou, Polytechnic Institute of NYU

512b

Ultrasonic and Liposomal Drug Delivery to Tumors
William G. Pitt, Brigham Young University; Ghaleb A. Husseini, American University of Sharjah; Beverly L. Roeder, Brigham Young University; David Dickinson, Brigham Young University; David R. Warder, Brigham Young University; Jonathan Hartley, Brigham Young University; Peter R. Jones, Brigham Young University

512c

Development of “Bulky” Lipid Microbubbles for Ultrasound Triggered Drug Delivery
Shashank R. Sirsi, Columbia University; Cherry Chen, Columbia University; Jameel Feshitan, Columbia University; James Kwan, Columbia University; Chinpong Fung, Columbia University; Henning Blomback, Columbia University; Mark A Borden, Columbia University

512d

Stimuli-Degradable Liposomes for Versatile Caner-Targeted Chemotherapy
Yoon Kyung Kim, University of California, Irvine; Young Jik Kwon, University of California, Irvine

Break

512e

Optimizing the Delivery of Nano-Medicine in Tumors: Implications for Tumor Normalization
James W. Baish, Bucknell University; Triantafyllos Stylianopoulos, Harvard Medical School and Massachusetts General Hospital; Rakesh K Jain, Harvard Medical School and Massachusetts General Hospital

512f

Polyvalent Presentation of Membrane-Lytic Peptides Enhances Antitumor Potency
Jieying Zhong, The Hong Kong University of Science and Technology; Ying Chau, The Hong Kong University of Science and Technology

512g

Directed Evolution of Novel Cell Penetrating Peptides for Delivery to the Brain
Shan Gao, Columbia University; Melissa J. Simon, Columbia University; Barclay Morrison III, Columbia University; Scott A. Banta, Columbia University

See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division

<< Previous Session | Next Session >>